Akt in cancer: Mediator and more
- PMID: 31173856
- DOI: 10.1016/j.semcancer.2019.06.002
Akt in cancer: Mediator and more
Abstract
Akt is a serine/threonine kinase and it participates in the key role of the PI3K signaling pathway. The Akt can be activated by a wide range of growth signals and the biochemical mechanisms leading to Akt activation are well defined. Once activated, Akt modulates the function of many downstream proteins involved in cellular survival, proliferation, migration, metabolism, and angiogenesis. The Akt is a central node of many signaling pathways and it is frequently deregulated in many types of human cancers. In this review, we provide an overview of Akt function and its role in the hallmarks of human cancer. We also discussed various mechanisms of Akt dysregulation in cancers, including epigenetic modifications like methylation, post-transcriptional non-coding RNAs-mediated regulation, and the overexpression and mutation.
Keywords: Akt; Akt inhibitor; Cancer hallmarks; Mutation; lncRNA; miRNA.
Copyright © 2019 Elsevier Ltd. All rights reserved.
Similar articles
-
Emerging role of PI3K/AKT in tumor-related epigenetic regulation.Semin Cancer Biol. 2019 Dec;59:112-124. doi: 10.1016/j.semcancer.2019.04.001. Epub 2019 Apr 2. Semin Cancer Biol. 2019. PMID: 30951826 Review.
-
Targeting AKT/PKB to improve treatment outcomes for solid tumors.Mutat Res. 2020 Jan-Apr;819-820:111690. doi: 10.1016/j.mrfmmm.2020.111690. Epub 2020 Feb 20. Mutat Res. 2020. PMID: 32120136 Free PMC article. Review.
-
The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications.Curr Cancer Drug Targets. 2008 May;8(3):187-98. doi: 10.2174/156800908784293659. Curr Cancer Drug Targets. 2008. PMID: 18473732 Review.
-
Role of the PI3K/AKT/mTOR signaling pathway in ovarian cancer: Biological and therapeutic significance.Semin Cancer Biol. 2019 Dec;59:147-160. doi: 10.1016/j.semcancer.2019.05.012. Epub 2019 May 22. Semin Cancer Biol. 2019. PMID: 31128298 Review.
-
PI3K/Akt/mTOR inhibitors in cancer: At the bench and bedside.Semin Cancer Biol. 2019 Dec;59:125-132. doi: 10.1016/j.semcancer.2019.07.009. Epub 2019 Jul 16. Semin Cancer Biol. 2019. PMID: 31323288 Review.
Cited by
-
TRIB3 promotes oral squamous cell carcinoma cell proliferation by activating the AKT signaling pathway.Exp Ther Med. 2021 Apr;21(4):313. doi: 10.3892/etm.2021.9744. Epub 2021 Feb 1. Exp Ther Med. 2021. PMID: 33717256 Free PMC article.
-
ITGA2 Overexpression Promotes Esophageal Squamous Cell Carcinoma Aggression via FAK/AKT Signaling Pathway.Onco Targets Ther. 2021 Jun 3;14:3583-3596. doi: 10.2147/OTT.S302028. eCollection 2021. Onco Targets Ther. 2021. PMID: 34113124 Free PMC article.
-
Network Pharmacology Based Elucidation of Molecular Mechanisms of Laoke Formula for Treatment of Advanced Non-Small Cell Lung Cancer.Chin J Integr Med. 2024 Nov;30(11):984-992. doi: 10.1007/s11655-024-3717-5. Epub 2024 Jun 28. Chin J Integr Med. 2024. PMID: 38941043
-
The Overexpression of Acyl-CoA Medium-Chain Synthetase-3 (ACSM3) Suppresses the Ovarian Cancer Progression via the Inhibition of Integrin β1/AKT Signaling Pathway.Front Oncol. 2021 Mar 31;11:644840. doi: 10.3389/fonc.2021.644840. eCollection 2021. Front Oncol. 2021. PMID: 33869039 Free PMC article.
-
Cordycepin Inhibits the Growth of Hepatocellular Carcinoma by Regulating the Pathway of Aerobic Glycolysis.Evid Based Complement Alternat Med. 2022 Nov 23;2022:6454482. doi: 10.1155/2022/6454482. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 36467556 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources